Brainstorm Cell Therapeutics | BCLI - Trade Creditors


Brainstorm Cell Therapeutics reported $7.07M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Biogen USD 358.5M 73.5M Mar/2026
Brainstorm Cell Therapeutics USD 7.07M 647K Dec/2025
Cipla INR 30.35B 1.98B Sep/2025
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.35M 6.77M Dec/2025
CSL USD 3.17B 290M Dec/2025
Cytokinetics USD 24.71M 80.91M Mar/2026
Gilead Sciences USD 715M 93M Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Mesoblast USD 33.58M 14.49M Dec/2025